Delhi HC restrains 4 pharma firms from making, selling 2 Novartis patent drugs Roshni Dhar10 Nov 2021 12:24 AM ISTIn a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan...
Health Bulletin 8 / November /2021 Roshni Dhar8 Nov 2021 4:53 PM ISTHere are Top Health Stories of the day Patient Dies Post Delivery Due to Heavy Bleeding: Consumer Court Slaps Hospital, Gynecologist, Surgeon with ...
HC restrains 4 pharma firms from making, selling Novartis Sacubitril, Valsartan tablets Ruchika Sharma2 Nov 2021 6:09 PM ISTNew Delhi: In a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or...
No significant benefit of sacubitril/valsartan after acute MI: PARADISE-MI trial Medha Baranwal25 Oct 2021 10:00 AM ISTUSA: Sacubitril/valsartan does not significantly reduce the risk of heart failure (HF) or cardiovascular (CV) death for immediate post-myocardial...
hs-TnT helps identify patients of HFpEF likely to benefit from sacubitril/valsartan: Study Dr. Shravani Dali29 July 2021 3:00 PM ISTThe baseline hs-TnT was linked with increased risk of cardiovascular death or Hospitalization due to heart failure and these patients tend to ...
Ace Inhibitors as good as Sacubitril/Valsartan in preventing CV events in MI with HF MD Bureau27 May 2021 10:00 AM ISTSacubitril/valsartan, the heart failure drugs did not significantly reduce the rate of cardiovascular death, heart failure hospitalization or...
Delhi HC Restrains Eris Lifesciences from Infringing Novartis Sacubitril, Valsartan FDC Medical Dialogues Team12 April 2021 5:53 PM ISTNew Delhi: Observing that Eris Lifescience Limited has sold all the infringed products as allowed by Telangana High Court, the Delhi High Court has...
Sacubitril, Valsartan combo effective in high risk heart failure patients: Circulation Medha Baranwal22 Feb 2021 10:30 AM ISTUSA: Treating high-risk patients hospitalized for acute decompensated heart failure with sacubitril/valsartan reduces the risk of CV death or...
